Development, preclinical evaluation and validation of a novel quick vascular closure device for transluminal, cardiac and radiological arterial catheterization
- 58 Downloads
Following percutaneous coronary intervention, vascular closure devices (VCDs) are increasingly used to reduce time to ambulation, enhance patient comfort, and reduce potential complications compared with traditional manual compression. Newer techniques include complicated, more or less automated suture devices, local application of pads or the use of metal clips and staples. These techniques often have the disadvantage of being time consuming, expensive or not efficient enough. The VCD failure rate in association with vascular complications of 2.0–9.5%, depending on the type of VCD, is still not acceptable. Therefore, the aim of this study is to develop a self-expanding quick vascular closure device (QVCD) made from a bioabsorbable elastic polymer that can be easily applied through the placed introducer sheath. Bioabsorbable block-co-polymers were synthesized and the chemical and mechanical degradation were determined by in vitro tests. The best fitting polymer was selected for further investigation and for microinjection moulding. After comprehensive haemocompatibility analyses in vitro, QVCDs were implanted in arterial vessels following arteriotomy for different time points in sheep to investigate the healing process. The in vivo tests proved that the new QVCD can be safely placed in the arteriotomy hole through the existing sheath instantly sealing the vessel. The degradation time of 14 days found in vitro was sufficient for vessel healing. After 4 weeks, the remaining QVCD material was covered by neointima. Overall, our experiments showed the safety and feasibility of applying this novel QVCD through an existing arterial sheath and hence encourage future work with larger calibers.
The study was funded by the Federal Ministry for Education and Research (BMBF) under the grant no. BMBF 01KQ0902 in the frame of the Gesundheitsregion REGiNA.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation. 2006;114:1321–41.CrossRefGoogle Scholar
- 5.Hepp WKH. editor. Interventionelle Maßnahmen in Gefäßchirurgie. München; 2006.Google Scholar
- 6.Erbel R, Pflicht, B, Kahlert, P, Konorza, T, editor. Herzkatheter-Manual: Diagnostik und interventionelle Therapie: Deutscher Ärzte-Verlag; 2012.Google Scholar
- 13.ISO 10993 Biological evaluation of medical devices. 2010.Google Scholar
- 15.McMillen C. The sheep—an ideal model for biomedical research? ANZCCART News. 2001;2:1–4.Google Scholar
- 22.Wong SC, Bachinsky W, Cambier P, Stoler R, Aji J, Rogers JH, et al. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure’s Vascular Closure Device Speeds Hemostasis Trial). JACC Cardiovasc Interv. 2009;2:785–93.CrossRefGoogle Scholar
- 25.Silver FH. Comparison of the histological responses observed at the arterial puncture site after employing manual compression. CathLab Dig. 2003;9:11.Google Scholar